Q326 IDEX Corporation Earnings Call - IDEX CORP

Explicit Guidance:

• FY2026 Organic Revenue Growth: Raised to 6.5% – 6.8% (previously 5% – 6%).
• FY2026 Adjusted EBITDA Margin: Tightened to 27.1% – 27.3% (previously 27.0% – 27.5%).
• FY2026 Adjusted EPS: Raised to $8.91 – $8.96 midpoint (previously $8.70 – $8.85), representing double-digit year-over-year growth.
• FY2026 Capital Expenditures (CapEx): Expected to remain approximately $110 million.
• FY2026 Free Cash Flow (FCF) Conversion: Expected to be at least 100%.
• FY2026 Share Repurchases: Planned to maintain buybacks at approximately $75 million per quarter for the remainder of 2026, with flexibility to exceed this based on leverage, M&A, or portfolio decisions.
• FY2027 Outlook: Management expects HST to grow in the high single digits and industrial businesses (FMT/FSDP) to outgrow their respective markets, targeting consolidated incremental margins of 38% – 40% net of reinvestment to sustain double-digit earnings growth.
• Q4 Specifics: Expects sequential margin step-down in Q4 due to fewer production days and planned maintenance shutdowns, consistent with historical patterns.

Business-Segment Outlook:

• HST Segment: Orders grew 21% organically in Q3; momentum is building with visibility extending into 2027. Growth driven by Semiconductor (consumables), Data Centers, and Space & Defense. Life sciences business expected to return to growth in 2027 as the legacy platform roll-off laps by year-end.
• FMT Segment: Organic sales grew 4% in Q3; long-lead time orders and base industrial businesses showing strength. Agriculture and Energy sectors showing sequential improvement despite year-over-year declines in chemicals and agriculture. Municipal Water (Intelligent Water Platform) and Semiconductor applications remain key growth drivers.
• FSDP Segment: Organic sales grew 6% in Q3, led by Bandit (aerospace/defense) and Dispensing returning to growth.
• Strategic Platforms: Material Science Solutions (Mott, Muon, Miwan) continuing to demonstrate "tunability," shifting resources to high-growth verticals (e.g., Muon from respiratory to optical circuit switching; Miwan to space RF antennas; Mott to semiconductor/filtration).
• Product/Technology: Paraspec (cloud-based intelligent water platform) expanding value proposition for municipalities; Data Center demand expected to remain healthy; Space launch capacity reaching an inflection point supporting robust growth.

Market and Competitive Outlook:

• Demand Trends: Strong demand in Data Centers, Semiconductor, Space, Defense, and Municipal Water. Industrial demand showing broadening and stabilization, particularly in Ag and Energy.
• Market Share & Competitiveness: IDEX leveraging component-level "tunability" to solve increasingly difficult technical problems in fast-growing verticals, commanding price ahead of cost.
• Pricing: Pricing power remains intact; Price-Cost contribution expected to remain positive in 2026 and 2027. Pricing contribution to top line estimated at ~2% for 2026.
• Growth Composition: Advantaged markets (Data Center, Semiconductor, Space/Defense) now represent >1/3 of HST portfolio, driving ~50% year-over-year growth in those specific areas.
• Infrastructure: Municipal Water trends driven by diagnostic analytics (Paraspec) helping clients identify issues before capital commitment.

Macro / Industry Outlook:

• Inflation & Costs: Input costs remain stubborn with elevated energy prices; IDEX model positioned to absorb costs via value-based pricing.
• Macro Environment: Broadening industrial demand indicators (Ag, Energy) suggest a floor has been established in previously fatigued areas; Chemicals remains the most challenged area due to input pricing.
• AI Impact: AI expected to accelerate innovation speed, data analysis, and regulatory decision-making in life sciences and industrial sectors.
• Data Center Capacity: Management monitoring aggregate system capacity as a potential governor on future expansion rates, though no current disruptions identified.

Strategic Initiatives:

• M&A: Pipeline remains active with focus on bolt-on acquisitions that attach to growth platforms and offer cross-business "tunability." Valuations in the broader M&A market viewed as robust; discipline maintained but proprietary discussions ongoing.
• Capital Allocation: Continued investment in CapEx to support growth; strong cash flow ($214M in Q3) funding both reinvestment and shareholder returns ($54M dividends, $75M buybacks in Q3).
• Operational Efficiency: Execution of 80-20 playbook to reallocate resources and capital to highest-yielding areas within existing platforms, driving margin expansion.
• Portfolio Optimization: "Tunability" allowing rapid pivoting to faster-growing verticals; examples include shifting Mott to semiconductors and Muon to data center optics.
• Long-term Strategy: Aiming for sustainable double-digit earnings growth via high 30s to 40% incremental margins.

Risks and Headwinds to Outlook:

• Data Center Lumpy Orders: Data center order streams described as "unpredictable" and coming in large tranches; supply chain calibration by customers may cause volatility.
• Chemicals Sector: Remains "fatigued" due to dependence on elevated input pricing.
• Macroeconomic Uncertainty: Broader economic conditions and environmental regulations remain standard oversight areas.
• Capacity Constraints: Potential system-level capacity constraints in high-growth markets (Data Center, etc.) could limit expansion rates, though no immediate bottlenecks seen at IDEX level.
• Corporate Overhead: Year-over-year corporate line costs may create a slight headwind to consolidated flow-through percentages.
• M&A Environment: Robust valuation levels in the M&A market could constrain aggressive transaction activity despite high interest.

Management Tone on the Future:

• Confidence Level: High confidence in the validation of the 5-year acquisition thesis and the durability of "advantage markets."
• Sentiment: Optimistic regarding the broadening of industrial demand and the "compounding effect" of execution. Management views the current strategy as having "significant runway ahead."
• Hedges: Explicitly notes the unpredictability of data center order timing and the lingering fatigue in the chemicals sector.
• Forward Look: Expresses excitement for the potential of AI to accelerate innovation pacing and emphasizes that the 2027 outlook will see the "lumping" of legacy platforms lap, further aiding life sciences growth.

Miscellaneous:

• Leverage: Gross leverage improved to 1.8x (from 2.1x year ago).
• Liquidity: Ended quarter with over $1.2 billion in liquidity.
• Order Book: Q3 orders totaled nearly $1 billion (up 13% organically); books-to-bills remained north of 1.0x.
• Backlog: Data center backlog noted as sufficient to "run out" with ample visibility.
• Q&A Highlights: Management confirmed that AI is driving "speed of analysis" and "decision making" rather than immediate direct volume spikes in all areas, though overall optimism in life sciences innovation is high.